PGLYRP1 Antikörper (AA 179-189)
Kurzübersicht für PGLYRP1 Antikörper (AA 179-189) (ABIN605023)
Target
Alle PGLYRP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 179-189
-
Marke
- IHC-plus™
-
Spezifität
- Human PGLYRP1 / PGRP.
-
Homologie
- Percent identity with other species by BLAST analysis: Human (100%), Gorilla (82%), Gibbon (82%), Monkey (82%), Ant (82%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide C-PGNQLYHLIQN from the C-terminus of human PGLYRP1 / PGRP (NP_005082.1). Percent identity with other species by BLAST analysis: Human (100%), Gorilla (82%), Gibbon (82%), Monkey (82%), Ant (82%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: IHC, IHC-P (3.75 μg/mL), Peptide-ELISA (1:4000, 0.3 - 1 μg/mL), WB (0.3 - 1 μg/mL)
Usage: Peptide ELISA: antibody detection limit dilution 1:4000. Western Blot: Approx 30kD band observed in lysates of cell line Jurkat (calculated MW of 21.7kD according to NP_005082.1). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Lu et al, J Biol Chem. 2006 Mar 3,281(9):5895-907, PMID: 16354652). Recommended concentration: 0.3-1 μg/mL. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- PGLYRP1 (Peptidoglycan Recognition Protein 1 (PGLYRP1))
-
Andere Bezeichnung
- PGLYRP1 / PGRP
-
Hintergrund
-
Name/Gene ID: PGLYRP1
Synonyms: PGLYRP1, PGLYRP, PGRPS, TAG7, PGRP, PGRP-S, TNFSF3L -
Gen-ID
- 8993
-
NCBI Accession
- NP_005082
-
UniProt
- O75594
-
Pathways
- Activation of Innate immune Response
Target
-